GB Patent

GB202410599D0 — Therapeutics useful synergistic combinations

Assigned to Ellipses Pharma Ltd · Expires 2024-09-04 · 2y expired

What this patent protects

Patent listed against Gavreto.

Drugs covered by this patent

Gavreto (PRALSETINIB) · Rigel Pharms

Patent Metadata

Patent number: GB202410599D0
Jurisdiction: GB
Classification: —
Expires: 2024-09-04
Drug substance claim: No
Drug product claim: No
Assignee: Ellipses Pharma Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.